Novo Nordisk B A/S

NOVO-B 
(NasdaqOMXC) 
 
dkk 289.00 <%= Resources.Global.txtUp %>
Updated 26/04/2018
Change % 1.30% Stock price increasing
Change 3.70 Stock price increasing
Volume 2,484,477
High DKK 289.15
Low DKK 284.80
Open DKK 284.80
ISIN DK0060534915
Prev close DKK 285.30
# of shares 1,962.56M
Market cap 567,181M DKK
Intraday

Market closed
Novo Nordisk B A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  289.00 1.7% Stock price increasing -1.6% Stock price decreasing -16.9% Stock price decreasing -9.2% Stock price decreasing 8.7% Stock price increasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2016
0
48,432
37,925
45,269
97,539
2015
107,927
49,444
34,860
46,969
91,799
2014
88,806
34,492
26,481
40,294
77,062
2013
83,572
31,493
25,184
42,569
70,337
2012
78,026
28,142
21,432
40,632
65,669
2011
66,346
22,374
17,097
37,448
64,698
2010
60,776
18,891
14,403
36,965
61,402
2009
51,078
14,933
10,768
35,734
54,742
2008
45,666
12,405
9,666
33,058
0
2007
41,889
8,955
8,535
32,223
0
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Indices Open
 
OMX Copenhagen 20 CAP 1,115.19 0.3% Stock price increasing 0.7% Stock price increasing -3.0% Stock price decreasing -6.2% Stock price decreasing -0.8% Stock price decreasing -2.5% Stock price decreasing

Company profile

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Targets for: Novo Nordisk B A/S

Ritzau Finans
 
Analyst
Target
Date
Novo/Jefferies: Sænker kursmålet til 315 kr.
Jefferies
315 ned
23/03/18
Novo/Jefferies: Kursmål justeres ned til 335 kr. fra 355 kr.
Jefferies
335 ned
26/02/18
KORR: Novo/UBS: Sænker kursmål med små 6 pct. til 350 kr.
UBS
350 ned
02/02/18
KORR: Novo/UBS: Sænker kursmål med små 6 pct. til 350 kr.
UBS
350 ned
02/02/18
Novo/UBS: Hæver kursmål med små 6 pct. til 370 kr.
UBS
370 op
02/02/18
Novo/Carnegie: Kursmålet løftes til 405 kr. fra 340 kr.
Carnegie
405 op
29/01/18
Novo/Nordea: Kursmålet løftes til 387 kr. fra 350 kr. - NY
Nordea
387 op
26/01/18
Novo/Nordea: Kursmålet løftes til 387 kr. fra 350 kr.
Nordea
387 op
26/01/18
Novo/Jefferies: Kursmål løftes til 355 kr.
Jefferies
355 op
16/01/18
Novo/JPMorgan: Hæver anbefaling til
JPMorgan
290 ingen ændring
29/12/17

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
27 April 2018 00:01:54
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180423.5 - EUROWEB6 - 2018-04-27 01:01:54 - 2018-04-27 00:01:54 - 1000 - Website: OKAY